Clinical Trial Update: Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating glofitamab and obinutuzumab in indolent non-Hodgkin lymphomas, including follicular lymphoma and marginal zone lymphoma, is ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Indolent Non-hodgkin Lymphoma
• Marginal Zone Lymphoma

Drugs mentioned

• Glofitamab (glofitamab)
• Obinutuzumab (obinutuzumab)

Snippet

Sponsor: Reid Merryman, MD | Conditions: Follicular Lymphoma, Marginal Zone Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING